“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year earlier, in 2023, and 1% at the start of 2021.

There were major breakthroughs in drug ... are five of the biggest highlights in medical achievements this year: Children with hereditary deafness regained their hearing thanks to a type of ...

Still, doctors often prescribe type 2 diabetes drugs for weight ... The other weight loss drugs in the top five are: Mounjaro (0.6%), Wegovy (0.3%), Zepbound (0.2%) and phentermine (0.2%).